Project Grant HT94252310571
Award Date
9/30/23
Completion Date
9/29/26
Dollars Obligated
$997K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
West Hollywood, CA 90048, USA
Similar Awards
The Defense Health Agency awarded a $997,343 Project Grant to Cedars-Sinai Medical Center under the Military Medical Research and Development (CFDA 12.420) program. The grant supports a multidimensional imaging data-driven approach for phenotyping multiple sclerosis. The research aims to transform healthcare for military service members and the broader public through innovative and impactful biomedical investigations spanning basic, applied, and translational research. The award period runs from...
The Defense Health Agency awarded a $974,043 Project Grant to Cedars-Sinai Medical Center under the Military Medical Research and Development (CFDA 12.420) program. The grant supports early cardiac biomarker research focused on inflammation and remodeling in Duchenne muscular dystrophy. This 4-year award, running from September 1, 2025 to August 31, 2029, will fund innovative biomedical investigations at Cedars-Sinai aimed at transforming healthcare for military service members and the broader...
The Defense Health Agency awarded Cedars-Sinai Medical Center a $2,674,057 Project Grant under the Military Medical Research and Development (CFDA 12.420) program. The grant, effective June 1, 2025 through May 31, 2029, will support advanced biomedical research to identify pathways of progression from acute pancreatitis to recurring acute pancreatitis and chronic pancreatitis. As a leading academic medical research center, Cedars-Sinai will leverage its expertise in translational research,...
The Department of Defense's Defense Health Agency awarded a $1,164,294 Project Grant to Cedars-Sinai Medical Center on September 15, 2024 under the Military Medical Research and Development (CFDA 12.420) program. The grant will fund a 4-year project to correlate prostate-specific membrane antigen (PSMA) expression with molecular profiles in prostate cancer. Cedars-Sinai, a non-profit hospital and academic medical center, will conduct this biomedical research to advance understanding of...
The Defense Health Agency awarded a $1,252,500 Project Grant to Cedars-Sinai Medical Center under the Military Medical Research and Development (CFDA 12.420) program. The grant supports advanced biomedical research to transform healthcare for military service members, veterans, and the broader public. Specifically, the grant will fund research on the structure, function, and inhibition of the ONECUT2 protein, which is a driver of prostate cancer. The research will be conducted at Cedars-Sinai...
Cedars-Sinai Medical Center will receive $501,000 through a two-year Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant will support the medical center's research project "CD44 Enhances Efficacy of the Chimeric Antigen Receptor T-Cell Therapy Against Prostate Cancer." Through this funding, Cedars-Sinai researchers will investigate using CD44 to improve the effectiveness of CAR T-cell therapy in treating...
The Defense Health Agency awarded Cedars-Sinai Medical Center a $501,000 Project Grant under the Military Medical Research and Development (CFDA 12.420) program. The grant, titled "LARGE ONCOSOMES AS DRIVERS OF PROSTATE CANCER BONE METASTASIS", will fund advanced biomedical research aimed at transforming healthcare for military service members and the broader public. The research will investigate the role of large oncosomes in prostate cancer bone metastasis, with the goal of...
This $1,251,673.00 Project Grant was awarded by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to Cedars-Sinai Medical Center on August 1, 2023. The grant will fund research aimed at re-engineering the intratumoral myeloid-macrophage compartment to enhance the response to radiation and immunotherapy in triple-negative breast cancer. The three-year project will be performed at Cedars-Sinai's facilities in West Hollywood, CA. As a leading...
This $4,089,970 Project Grant awarded by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) supports research at Cedars-Sinai Medical Center to investigate spatial reprogramming of tumor immune microenvironments through preoperative radiotherapy and immune checkpoint inhibition in HER2 negative breast cancer. The award will fund basic, translational, and clinical research over 4 years from September 2023 to August 2027 to develop new treatments,...
The Department of the Army Medical Command awarded Cedars-Sinai Medical Center a $1,252,233 Project Grant on September 30, 2022 to support research titled "NOVEL LINEAGE PLASTICITY INHIBITORS IN PROSTATE CANCER." The grant is part of the Military Medical Research and Development program (CFDA 12.420), which aims to transform military and public health care through innovative biomedical research solutions for battlefield medicine and other health issues. Under this award, Cedars-Sinai...